Patents Assigned to Mannatech, Incorporated
  • Patent number: 9855288
    Abstract: The present invention includes compositions and methods of making and using a dietary supplement manufactured from one or more natural polysaccharides previously incubated with a probiotic bacteria in a bioreactor system, wherein the bacteria process the polysaccharides and the resulting processed polysaccharide are provided in the nutritional supplement.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: January 2, 2018
    Assignee: MANNATECH, INCORPORATED
    Inventor: Robert A. Sinnott
  • Publication number: 20120276208
    Abstract: Compositions and methods to improve cognitive performance and mood in an adult human subject's are presented herein. The method of the present invention involved the administration of a dietary supplement comprising plant polysaccharides. The compositions disclosed herein have beneficial effects on memory performance and tasks of high cognitive demand independent of blood glucose responses and despite mental fatigue.
    Type: Application
    Filed: April 23, 2012
    Publication date: November 1, 2012
    Applicants: UNIVERSITY OF SOUTH AUSTRALIA, MANNATECH, INCORPORATED
    Inventor: Talitha Best
  • Publication number: 20120208214
    Abstract: The present invention includes compositions, methods, kits and diagnostics for biosugar profiling of biological samples from a patient suspected of having a disease associated with changes in the biosugar profile. The biosugar profile from the patient sample is compared to a healthy biosugar profile from the same type of biological sample to evaluate disease potential and progression.
    Type: Application
    Filed: April 4, 2012
    Publication date: August 16, 2012
    Applicant: MANNATECH, INCORPORATED
    Inventor: John Axford
  • Patent number: 8231914
    Abstract: The present invention provides a performance assay that measures the total antioxidant activity of a composition using oxygen uptake in contrast to prior art methods that measure antioxidant capacity by indirectly measuring degradation of a fluorescent compound by following the disappearance of fluorescence. Using the performance antioxidant assay of the present invention, an antioxidant composition having synergistic activity is provided by the present inventors that includes flavonoids such as the flavonol quercetin, mixed tocopherols or tocotrienols, grape skin extract, green tea extract and bush plum. The antioxidant activity of the present composition exceeds 6,000 micromoles Trolox equivalent units per gram using the present invention.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: July 31, 2012
    Assignee: Mannatech Incorporated
    Inventors: Bill H. McAnalley, Eileen P. Vennum, Shayne McAnalley, C. Michael Koepler
  • Patent number: 8173437
    Abstract: The present invention includes compositions, methods, kits and diagnostics for biosugar profiling of biological samples from a patient suspected of having a disease associated with changes in the biosugar profile. The biosugar profile from the patient sample is compared to a healthy biosugar profile from the same type of biological sample to evaluate disease potential and progression.
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: May 8, 2012
    Assignee: Mannatech, Incorporated
    Inventor: John Axford
  • Publication number: 20110256248
    Abstract: The present invention provides a performance assay that measures the total antioxidant activity of a composition using oxygen uptake in contrast to prior art methods that measure antioxidant capacity by indirectly measuring degradation of a fluorescent compound by following the disappearance of fluorescence. Using the performance antioxidant assay of the present invention, an antioxidant composition having synergistic activity is provided by the present inventors that includes flavonoids such as the flavonol quercetin, mixed tocopherols or tocotrienols, grape skin extract, green tea extract and bush plum. The antioxidant activity of the present composition exceeds 6,000 micromoles Trolox equivalent units per gram using the present invention.
    Type: Application
    Filed: June 28, 2011
    Publication date: October 20, 2011
    Applicant: MANNATECH, INCORPORATED
    Inventors: Bill H. McAnalley, Eileen Vennum, Shayne A. McAnalley, C. Michael Koepke
  • Patent number: 7999003
    Abstract: The present invention provides a performance assay that measures the total antioxidant activity of a composition using oxygen uptake in contrast to prior art methods that measure antioxidant capacity by indirectly measuring degradation of a fluorescent compound by following the disappearance of fluorescence. Using the performance antioxidant assay of the present invention, an antioxidant composition having synergistic activity is provided by the present inventors that includes flavonoids such as the flavonol quercetin, mixed tocopherols or tocotrienols, grape skin extract, green tea extract and bush plum. The antioxidant activity of the present composition exceeds 6,000 micromoles Trolox equivalent units per gram using the present invention.
    Type: Grant
    Filed: August 26, 2003
    Date of Patent: August 16, 2011
    Assignee: Mannatech, Incorporated
    Inventors: Bill H. McAnalley, Eileen Vennum, Shayne A. McAnalley, C. Michael Koepke
  • Publication number: 20100234297
    Abstract: A food or pharmaceutical agent is provided for treating or offsetting the risks of a disease or disorder such as a cardiovascular disease, a hypercholesterolemia disorder, a low serum high density lipid (HDL)/low density lipid (LDL) ratio, a hypertriglyceridemia disorder, and diabetes includes a pharmaceutical carrier, and a composition including a purified glucomannan and at least one galactomannan. A method for treating or offsetting the risks of such a disease or disorder includes the step of administering to a human in need thereof an effective amount of the pharmaceutical composition to treat the cardiovascular disease.
    Type: Application
    Filed: April 12, 2010
    Publication date: September 16, 2010
    Applicant: MANNATECH, INCORPORATED
    Inventor: Robert A. Sinnott
  • Publication number: 20100215687
    Abstract: A food or pharmaceutical agent is provided for treating or offsetting the risks of a disease or disorder such as a cardiovascular disease, a hypercholesterolemia disorder, a low serum high density lipid (HDL)/low density lipid (LDL) ratio, a hypertriglyceridemia disorder, and diabetes includes a pharmaceutical carrier, and a composition including a purified glucomannan and at least one galactomannan. A method for treating or offsetting the risks of such a disease or disorder includes the step of administering to a human in need thereof an effective amount of the pharmaceutical composition to treat the cardiovascular disease.
    Type: Application
    Filed: April 12, 2010
    Publication date: August 26, 2010
    Applicant: MANNATECH, INCORPORATED
    Inventor: Robert A. Sinnott
  • Publication number: 20100216742
    Abstract: A food or pharmaceutical agent is provided for treating or offsetting the risks of a disease or disorder such as a cardiovascular disease, a hypercholesterolemia disorder, a low serum high density lipid (HDL)/low density lipid (LDL) ratio, a hypertriglyceridemia disorder, and diabetes includes a pharmaceutical carrier, and a composition including a purified glucomannan and at least one galactomannan. A method for treating or offsetting the risks of such a disease or disorder includes the step of administering to a human in need thereof an effective amount of the pharmaceutical composition to treat the cardiovascular disease.
    Type: Application
    Filed: April 12, 2010
    Publication date: August 26, 2010
    Applicant: MANNATECH, INCORPORATED
    Inventor: Robert A. Sinnott
  • Publication number: 20100215689
    Abstract: A food or pharmaceutical agent is provided for treating or offsetting the risks of a disease or disorder such as a cardiovascular disease, a hypercholesterolemia disorder, a low serum high density lipid (HDL)/low density lipid (LDL) ratio, a hypertriglyceridemia disorder, and diabetes includes a pharmaceutical carrier, and a composition including a purified glucomannan and at least one galactomannan. A method for treating or offsetting the risks of such a disease or disorder includes the step of administering to a human in need thereof an effective amount of the pharmaceutical composition to treat the cardiovascular disease.
    Type: Application
    Filed: April 12, 2010
    Publication date: August 26, 2010
    Applicant: MANNATECH, INCORPORATED
    Inventor: Robert A. Sinnott
  • Publication number: 20100216719
    Abstract: A food or pharmaceutical agent is provided for treating or offsetting the risks of a disease or disorder such as a cardiovascular disease, a hypercholesterolemia disorder, a low serum high density lipid (HDL)/low density lipid (LDL) ratio, a hypertriglyceridemia disorder, and diabetes includes a pharmaceutical carrier, and a composition including a purified glucomannan and at least one galactomannan. A method for treating or offsetting the risks of such a disease or disorder includes the step of administering to a human in need thereof an effective amount of the pharmaceutical composition to treat the cardiovascular disease.
    Type: Application
    Filed: April 12, 2010
    Publication date: August 26, 2010
    Applicant: MANNATECH, INCORPORATED
    Inventor: Robert A. Sinnott
  • Publication number: 20090004220
    Abstract: Compositions of plant carbohydrates for dietary supplements and nutritional support for promotion and maintenance of good health. Defined nutritionally effective amounts of one to eleven essential saccharides, glyconutrients, are used in various inventive compositions as dietary supplements. The dietary composition herein can include phytonutrients, vitamins, minerals, herbal extracts, and other non-toxic nutrients. The glyconutritional dietary supplement herein provides essential saccharides which are the building blocks of glycoproteins. These compositions, when administered orally or topically, have been found to improve the well being of mammals suffering from a variety of disorders.
    Type: Application
    Filed: September 11, 2008
    Publication date: January 1, 2009
    Applicant: MANNATECH, INCORPORATED
    Inventors: Bill H. McAnalley, H. Reginald McDaniel, D. Eric Moore, Eileen P. Vennum, William C. Fioretti